DocuSign director Anna Marrs sells $36,716 of common stock
DocuSign director Anna Marrs sold 548 shares at $67.0 each, totaling $36,716, under a 10b5-1 plan. She owns 13,525 shares. DOCU stock rose to $71.85, up 52% in six months. InvestingPro rates its financial health as 'GREAT'. Q2 revenue grew 9.4%, with analysts raising price targets to $60-$75. Needham maintains a Hold rating.
How this was made
The 30-second read
Why it matters
The insider sale adds a minor data point but does not change the overall bullish outlook from recent earnings.
Market read
Limited relevance; primarily of interest to shareholders monitoring insider activity.
What to watch
Potential upcoming dilution or secondary offering not mentioned.
Background
DocuSign reported Q2 results with revenue growth and raised price targets, but the article focuses on the insider sale.
Ticker impact
Director Anna Marrs sold 548 shares for $36,716 under a Rule 10b5-1 plan on Sep 14, 2026.
Minimal effect on DOCU price; likely unchanged.
The transaction size is modest relative to market cap and follows a pre‑planned trading plan, limiting informational value.
Market effects
None; the filing does not affect the broader e‑signature sector.
No regional impact; limited to DocuSign investors.
Low; the news is company‑specific and not market‑wide.
Counterpoint
The sale could be interpreted as insider confidence if the remaining holdings are sizable.
Key entities
- companyDocuSign Inc.
Provider of electronic signature and agreement cloud services.
- personAnna Marrs
Director at DocuSign who executed the stock sale.


